Aptuit Chief Executive Satyanarayana Chava said his company sells the bulk drug to Aspen Pharmacare Holdings Ltd.
WSJ: Researchers Manipulate HIV Drug's Chemistry to Lower Cost
应用推荐
模块上移
模块下移
不移动